Skip to main content
Cangene Corporation logo

Cangene Corporation — Investor Relations & Filings

Ticker · CNJ ISIN · CA13758B1022 TSX Manufacturing
Filings indexed 0 across all filing types
Latest filing no filings yet
Country CA Canada
Listing TSX CNJ

About Cangene Corporation

http://www.cangene.com

Cangene Corporation was a biopharmaceutical company focused on the development, manufacture, and commercialization of specialty therapeutics. The company's core expertise involved plasma-derived products, primarily hyperimmunes. Hyperimmunes are concentrated specialty antibody preparations derived from specialty plasma, functioning as protein-based therapeutics utilized in the treatment of immune system conditions, including infectious diseases. Cangene also engaged in the development of recombinant products and offered contract manufacturing and development services to external biopharmaceutical clients.

Recent filings

No filings indexed yet

We are still gathering filings for Cangene Corporation. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.